GURRIERI, CARMELA
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 45
AS - Asia 41
SA - Sud America 1
Totale 219
Nazione #
US - Stati Uniti d'America 131
CN - Cina 36
FR - Francia 19
IT - Italia 14
AE - Emirati Arabi Uniti 5
DE - Germania 4
IE - Irlanda 3
NL - Olanda 2
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
UA - Ucraina 1
Totale 219
Città #
Beijing 34
Fairfield 13
Chicago 11
Buffalo 8
Seattle 8
Ashburn 7
New York 7
Santa Cruz 6
Houston 5
Padova 5
Des Moines 4
Los Angeles 4
Dallas 3
Dublin 3
Wilmington 3
Woodbridge 3
Ann Arbor 2
Atlanta 2
Cambridge 2
Crugers 2
Due Carrare 2
Henderson 2
Herndon 2
Paris 2
Belluno 1
Boardman 1
Cagliari 1
Cedar Knolls 1
Council Bluffs 1
Dulles 1
Honolulu 1
Manchester 1
Miami 1
Osimo 1
Pasadena 1
Rochester 1
Rome 1
San Diego 1
San Francisco 1
San Jose 1
Scottsdale 1
Verona 1
Totale 158
Nome #
Comparison of presepsin, procalcitonin, interleukin-8 and C-reactive protein in predicting bacteraemia in febrile neutropenic adult patients with haematological malignancies, file e14fb26c-b6d0-3de1-e053-1705fe0ac030 122
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis, file e14fb26e-e72d-3de1-e053-1705fe0ac030 34
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma, file d6c9fd8e-1502-4765-9914-2c02188633d7 14
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma, file e14fb26f-94c8-3de1-e053-1705fe0ac030 14
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells, file e14fb267-aa92-3de1-e053-1705fe0ac030 11
A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection, file cc5f4ec7-9e9b-4eb1-b070-c9ae9bf08256 7
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma, file cd5f1876-bb2b-4db5-8024-55385fcaa4bc 7
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity, file e14fb267-aa65-3de1-e053-1705fe0ac030 6
Images in cardiovascular medicine. Right atrial mass in a patient with T-cell chronic lymphocytic leukemia: an unusual mechanism of thrombus formation., file e14fb267-7178-3de1-e053-1705fe0ac030 3
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis, file e14fb267-84ef-3de1-e053-1705fe0ac030 1
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia, file e14fb268-fb50-3de1-e053-1705fe0ac030 1
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response, file e14fb269-2342-3de1-e053-1705fe0ac030 1
Totale 221
Categoria #
all - tutte 1.266
article - articoli 1.266
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 1 1 0 0 0 3 4 3 0 3
2021/202235 1 8 3 3 1 0 5 0 1 1 10 2
2022/202399 5 6 7 1 7 2 0 20 40 1 9 1
2023/202470 0 0 2 0 1 9 11 28 15 4 0 0
Totale 221